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Carotid intimal medial thickness (IMT) is a heritable quantitative measure of atherosclerosis. A genomewide linkage
analysis was conducted to localize a quantitative-trait locus (QTL) inﬂuencing carotid IMT. Carotid IMT was
measured in 596 men and 629 women from 311 extended families (1,242 sib pairs) in the Framingham Heart
Study Offspring cohort. B-mode carotid ultrasonography was used to deﬁne mean IMT of the carotid artery
segments. Multipoint variance-component linkage analysis was performed. Evidence for signiﬁcant linkage to in-
ternal carotid artery (ICA) IMT (two-point log odds [LOD] score 4.1, multipoint LOD score 3.4) was found 161
cM from the tip of the short arm of chromosome 12; these results were conﬁrmed using the GENEHUNTER
package (multipoint LOD score 4.3). No LOD scores 12.0 were observed for common carotid artery (CCA) IMT.
Association analysis of a single-nucleotide–polymorphism variant of SCARB1 (minor allele frequency 0.13), a gene
in close proximity to the region of peak linkage, revealed a protective association of the missense variant allele in
exon 1 of SCARB1, with decreased ICA IMT compared with subjects homozygous for the common allele. Although
the exon 1 variant contributed 2% to overall variation in ICA IMT, there was no signiﬁcant change in the peak
LOD score after adjustment in the linkage analyses. These data provide substantial evidence for a QTL on chro-
mosome 12 inﬂuencing ICA IMT and for association of a rare variant of SCARB1, or a nearby locus, with ICA
IMT. Because this rare SCARB1 variant does not account for our observed linkage, further investigations are
warranted to identify additional candidate-gene variants on chromosome 12 predisposing to atherosclerosis phe-
notypes and clinical vascular disease.
Introduction
Atherosclerotic cardiovascular disease (CVD) is the lead-
ing cause of morbidity and mortality in the United States
(American Heart Association 2002). Both genetic and
environmental factors have been implicated in the path-
ogenesis of atherosclerosis (Lusis 2000). Carotid artery
intimal medial thickness (IMT) is a measure of athero-
sclerosis that is independently associatedwith traditional
CVD risk factors (Crouse et al. 1996; Espeland et al.
1999) and coronary atherosclerotic burden (O’Leary et
al. 1996; Davis et al. 1999) and that is predictive of
subsequent myocardial infarction and stroke (Bots et al.
1997; O’Leary et al. 1999). Carotid IMT is associated
with a family history of cardiovascular disease, and we
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have shown that 35%–45% of the variability in mul-
tivariable-adjusted carotid IMT is explained by genetic
factors (Fox et al. 2003). However, few large population-
based analyses of genomewide linkage exist for vas-
cular phenotypes, and there are few signiﬁcant genome-
wide linkage data available in the general population for
myocardial infarction or the underlying condition of
atherosclerosis.
Thus, we conducted a genomewide linkage analysis
in a population-based cohort of families, to identify
chromosomal regions linked to interindividual variation
in carotid IMT. We followed up with association anal-
yses of polymorphisms in a plausible candidate gene in
the region of peak linkage.
Material and Methods
Study Population
In the current investigation, subjects from the Fra-
mingham Heart Study Offspring cohort underwent B-
mode carotid ultrasonography during examination cycle
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6 (1996–1998). Carotid IMT was measured in 596 men
and 629 women, included in 311 extended families and
1,242 sib pairs.
The Framingham Heart Study began in 1948 with the
enrollment of 5,209 men and women, 28–62 years of
age at study entry, with subjects undergoing repeat ex-
ams every 2 years (Dawber et al. 1951, 1963). In 1971,
5,124 men and women were enrolled in the offspring
cohort of the Framingham Heart Study, which included
the children or spouses of the children of the original
cohort. Offspring subjects underwent examinations ap-
proximately every 4 years; the design and methodology
of the offspring cohort has been described elsewhere
(Feinleib et al. 1975; Kannel et al. 1979).
For the linkage analysis, 3,532 subjects attended cycle
6 of the total 5,124 subjects that attended the initial
offspring exam. Of these, 152 did not undergo carotid
ultrasound, 2,137 were excluded because they were not
a biologic member of a family that was genotyped in
the marker set for the linkage analysis, a further 17 were
excluded because they were not part of a biologic family
whose members had carotid ultrasound data, and 1 was
excluded because of inadequate carotid IMT data. Thus,
a total of 1,225 subjects in 311 families comprised the
study sample. Of these, all had an available common
carotid artery (CCA) measurement, and 1,113 had an
available internal carotid artery (ICA) measurement.
For the genotyping of the gene encoding scavenger
receptor, class B, type I (SCARB1 [MIM 601040]), pre-
viously known as SR-BI, in the association portion of
this study, DNA samples from 2,342 individuals who
attended cycle 6 were used. Of these, 96 subjects were
excluded because they did not undergo carotid ultra-
sound, and 1 was excluded because of inadequate ca-
rotid IMT data. In all, 2,245 subjects had at least one
carotid IMT measure and were typed for at least one of
the SCARB1 polymorphisms; therefore, they were in-
cluded in these analyses. A total of 736 subjects appear
in both the linkage and association analyses.
Assessment of Risk Factors and Cardiovascular Disease
Details regarding the methods of risk factor measure-
ment and laboratory analysis have been described (Cup-
ples and D’Agostino 1987). Each examination included
an extensive cardiovascular disease assessment, 12-lead
electrocardiogram (ECG), and blood testing. Measured
covariates for the current study were assessed at the time
of carotid ultrasonography.
Carotid Intimal Medial Thickness Assessment
Subjects underwent ultrasonography according to a
modiﬁcation of a standard protocol (O’Leary et al.
1999). Imaging was conducted by a single trained son-
ographer, using a Toshiba SSH-140A imaging unit and
7.0-MHz transducer for the CCA and a 5.0-MHz trans-
ducer for the ICA.
The following views were obtained from the right and
left sides: two longitudinal views of the distal common
carotid, one at end diastole and one at end systole, and
two longitudinal views of the ICA at end diastole. Mea-
surements were made by a single trained sonographer
blinded to all clinical information, and they were over-
read by one of the investigators (J.F.P.).
All studies were read according to a standardized pro-
tocol. The high-resolution images of the ICA and CCA
were analyzed to calculate near- and far-wall IMT, lumen
diameter, and vessel width at each arterial site. All mea-
surements of lumen and wall thickness were calculated
with a specially designed computer program (O’Leary
et al. 1996, 1999). On the basis of 25 replicate readings
by two separate readers, intraclass correlation coefﬁ-
cients for the mean and maximum ICA and CCA IMT
were 0.74, 0.74, 0.86, and 0.90, respectively.
A summary measure of the mean wall thickness of the
ICA was deﬁned as the mean of the wall thickness for
the near and far wall on both the left and right sides.
Similar measurements were obtained for the CCA.
Genotyping
Leukocyte DNA was extracted from 5–10 mL of
whole-blood or buffy-coat specimens by use of a stan-
dard protocol (Gross-Bellard et al. 1973; Miller et al.
1988). Aliquots of DNA from members of the largest
Framingham Heart Study families were sent in four
batches to the Mammalian Genotyping Service Labo-
ratory at the Marshﬁeld Clinic (Marshﬁeld, WI). A 10-
cM density genomewide scan was performed (marker
set 8A, heterozygosity 0.77). Genotype-data cleaning,
including veriﬁcation of family relationships and Men-
delian inconsistencies, has been described elsewhere
(Levy et al. 2000). In brief, familial relationships were
checked using the SIBKIN program in ASPEX, which
uses maximum-likelihood estimation to test whether the
genotyping data are consistent with the speciﬁed rela-
tionships, and adjustments were made accordingly. In
addition, random genotyping errors were checked using
Gentest, a precursor to the INFER procedure, in PED-
SYS. When we discovered a genotyping error and could
not attribute it to a speciﬁc person in a nuclear family,
all genotypes for that nuclear family were assigned as
missing.
Known mutations in SCARB1 (Acton et al. 1999; Os-
good-McWeeney et al. 2000) were identiﬁed by direct
sequencing of PCR products. Three polymorphismswere
typed: one in exon 1, one in exon 8, and one in intron
5. SCARB1 genotyping was carried out by allelic dis-
crimination by use of the 5′ nuclease assay with ﬂuo-
rogenic probes on a 7700 Sequence Detection System
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(PE Applied Biosystems), as described elsewhere (Os-
good-McWeeney et al. 2000).
Linkage Analysis
Our statistical analysis focused on mean IMT mea-
sures of the ICA and CCA. The heritabilities for CCA
and ICA IMT have been published elsewhere (Fox et al.
2003). Before multivariable adjustment, the heritabilities
were 0.67 for CCA IMT and 0.43 for ICA IMT. After
multivariable adjustment, the heritabilities were 0.43
and 0.35, respectively.
Because the distributions of carotid measures were
skewed, normalized deviates were used. Multivariable-
adjusted normalized deviates were calculated using the
SAS/STAT user’s guide, version 8 (SAS Institute Inc.
2000); all linkage data presented ismultivariable adjusted.
For these adjustments, we used multiple linear regression
separately for men and women, to obtain standardized
residuals. These standardized residuals were then ranked,
and normalized deviates were calculated. Covariates in
themultivariablemodels included age, systolic bloodpres-
sure, number of cigarettes per day, total and HDL cho-
lesterol, log-triglycerides, diabetes status (yes/no), body
mass index, antihypertensive treatment (yes/no), meno-
pausal status (yes/no), and hormone-replacement therapy
in women (yes/no). All covariates were continuous except
where otherwise speciﬁed.
For the linkage analysis, there were a total of 311
extended families, with 2–24 individuals each. There
were 1,242 sib pairs (sibships range from two to seven
individuals), 100 avuncular pairs, 39 half siblings, and
716 ﬁrst cousins. Subjects were contained in sibships in
the following distribution: 47% had two members, 32%
had three members, 14% had four members, and 7%
had ﬁve or more members.
Two-point and multipoint quantitative-trait linkage
analyses were conducted with the normalized deviates
for the carotid IMT measures by use of the SOLAR
package (Almasy and Blangero 1998). This approach
uses information on available marker data and the fam-
ily structure to impute genotypes for untyped individ-
uals. Estimates of the proportion of alleles with shared
identity by descent (IBD) are then obtained for all rel-
ative pairs. By imputing genotypes for untyped individ-
uals, SOLAR makes use of all individuals with carotid
IMT measures in the linkage analysis. To assess linkage,
a ﬁtted model with no genetic marker information (poly-
genic model) is used and compared with a ﬁtted model
that incorporates genetic marker information at a spe-
ciﬁc marker (two-point analysis) or across a chromo-
some (multipoint analysis). To obtain the log odds
(LOD) score, the log (base 10) of the ratio of the like-
lihoods of the marker-speciﬁc and polygenic models is
computed. We have veriﬁed our results by use of GENE-
HUNTER (Kruglyak et al. 1996), an alternative statis-
tical linkage program, conducted to address the sugges-
tion by some critics of SOLAR that the multipoint IBD
estimates calculated by GENEHUNTER are superior to
those calculated by SOLAR (Ekstrom 2001).
We used SOLAR to estimate power and type 1 error.
We used the function “simqtl” in SOLAR (Almasy and
Blangero 1998) to simulate both a linked and an un-
linked quantitative trait for power and type 1 error anal-
ysis, respectively. Given the family structure and the ap-
proximate number of individuals with trait values used
in these analyses, we have 63%–95% power to detect
a QTL that accounts for 25%–35% of the variation in
the carotid IMT traits if we use a LOD score 12 as our
critical value, and we have 37%–84% power for a LOD
score 13. In addition to power, we conducted 100 sim-
ulations of our genomewide scan by use of unlinked
phenotypes, to assess the risk of false-positive results.
The genomewide chance is only 4% of a LOD score in
our data being 13 when there is no genomewide linkage.
This indicates that the chance of our results being a false
positive is !4%, controlling for genomewide multiple
testing.
Association Analysis
To evaluate the association between the SCARB1 gene
and carotid IMT, a total of 2,245 individuals were in-
cluded in the analysis. These individuals had at least one
carotid IMT measure and were genotyped for at least
one of the three SCARB1 polymorphisms considered.
The majority of individuals (1,435) included in these
analyses were members of families, with 2–14 individ-
uals each. Association analyses for polymorphisms in
the SCARB1 gene were analyzed using the SAS proce-
dure PROC MIXED (SAS Institute Inc. 2000). This
methodology uses a maximum-likelihood procedure, as-
suming a normal distribution of the phenotypes, to es-
timate the regression coefﬁcients in a mixed-effectmodel
that incorporates ﬁxed effects for known covariates and
speciﬁc genotypes and random effects to account for the
correlation among members in the same families. Nor-
malized deviates of crude IMT measures were used in
these analyses to meet the normality assumption.
To evaluate individual effects of the SCARB1 poly-
morphisms on carotid IMT, we created two dichoto-
mous variables. The signiﬁcance of covariates and ge-
notype effects was assessed by comparing a ﬁtted model
in which ﬁxed effects for known covariates, genotypes,
and random effects were included, with amodel inwhich
the two dummy variable-regression coefﬁcients were set
to zero. We calculated crude and multivariable-adjusted
models, including the following covariates: age, sex, sys-
tolic blood pressure, number of cigarettes per day, total
and HDL cholesterol, log-triglycerides, diabetes status
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Table 1
Baseline Characteristics of Study Subjects
CHARACTERISTIC
FINDING IN SAMPLE
Linkage
( )np 1,225
Association
( )np 2,245
Age (years)a 56  10 59  10
Sex (% male) 49 48
Systolic blood pressure (mm Hg)a 125  18 129  19
Total cholesterol (mg/dL)a 206  43 205  40
Triglycerides (mg/dL)a 144  178 142  151
High-density lipoprotein cholesterol (mg/dL)a 51  15 51  16
Body mass index (kg/m2) a 28.2  5.5 28.0  5.1
Current smoking (%) 17 15
Postmenopause (%) 70 79
Hormone replacement therapy (%) 22 28
Prevalent hypertension (%) 35 43
Hypertension treatment (%) 24 30
Diabetes (%) 5 6
Cardiovascular disease (%) 9 11
Carotid artery IMT (mm)a:
Common .59  .15 .61  .16
Internal .56  .36 .59  .39
NOTE.—To convert total and high-density lipoprotein frommg/dL tommol/
L, multiply by .0259. To convert triglycerides frommg/dL tommol/L,multiply
by .0113.
a Mean  SD.
(yes/no), body mass index, antihypertensive treatment
(yes/no), menopausal status (yes/no), and hormone-re-
placement therapy in women (yes/no). To parallel the
linkage analysis, the association analysis was repeated
using sex-speciﬁc multivariable-adjusted residuals.
Results
Study Sample
The characteristics of the study samples used in the
linkage and association analyses are shown in table 1.
The mean age was 56 years in the linkage sample and
59 years in the association sample. Mean cholesterol,
triglycerides, and HDL cholesterol were similar in both
groups; the prevalence of hypertension and hypertension
treatment was higher in the association sample.
Mean CCA and ICA IMT values are presented in table
1. The CCA values ranged from 0.33–3.25 mm; the ICA
values ranged from 0.20–3.94 mm. The correlation be-
tween ICA and CCA IMT is 0.48 ( ).P ! .001
Multivariable-Adjusted Two-Point and Multipoint
Linkage
For the ICA, we observed a maximum two-point LOD
score of 4.1 at 161 cM on chromosome 12, with a small
secondary peak on chromosome 1 (LOD score 2.4 at 76
cM) and a maximummultipoint LOD score of 3.4 at 160
cM on chromosome 12 (ﬁg. 1). The marker at the peak
LOD score on chromosome 12 was D12S1045. The high-
est multipoint LOD scores for ICA and CCA IMT for
each of the 22 autosomes are presented in ﬁgure 2. For
CCA IMT, we observed a peak multipoint LOD score of
1.99 on chromosome 2 at 105 cM. The marker nearest
to the peak LOD score on chromosome 2 was D2S1790.
UsingGENEHUNTER,we conﬁrmed our results on chro-
mosome 12, with a multipoint LOD score of 4.3 in the
same region identiﬁed by SOLAR. Table 2 presents all
LOD scores 11.0 for ICA and CCA IMT. The two-point
and multipoint ICA IMT linkage results for all chromo-
somes appear as an online-only supplement.
Association Analysis of Common Variants in SCARB1
SCARB1 is an atherosclerosis candidate gene that re-
sides at 124.9 Mb, ∼5 million base pairs away from the
microsatellite marker D12S1045. Allele frequencies for
the rare alleles in exons 1 and 8 and intron 5 were 0.13,
0.49, and 0.09, respectively. All polymorphisms were in
Hardy-Weinberg equilibrium. In crude analyses, the
exon 1 variant was signiﬁcantly associated with ICA
IMT ( ); crude (i.e., prior to the calculation ofP ! .007
normalized deviates) ICA IMT values, arranged by exon
1 variant genotype, are presented in ﬁgure 3. In multi-
variable-adjusted analyses, subjects who are homozy-
gous for the rare allele had a mean ICA IMT that was
0.5 normalized SDs lower than the rest of the population
( for differences among all three groups). The useP ! .02
of sex-speciﬁc multivariable-adjusted residuals resulted
in similar differences in themagnitude of mean ICA IMT,
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Figure 1 Two-point and multipoint LOD scores for ICA IMT, chromosome 12
as compared with the rest of the population, but the P
value was attenuated ( ). Including the exon 1Pp .12
variant as a covariate in the variance-component anal-
ysis in SOLAR revealed that it accounted for 2% of the
overall variability in ICA IMT, whereas the additional
covariates accounted for 36% of the total variation in
CCA IMT, and 21% of the total variation for ICA IMT.
In further multivariable analyses with ICA IMT, there
were no signiﬁcant associations with variants in either
exon 8 or intron 5.
In a subanalysis conducted on subjects included in the
genomewide linkage analysis and typed for SCARB1
( ), multipoint LOD scores were calculated, afternp 736
adjustment for the exon 1 genotype of SCARB1. The
multivariable-adjusted LOD score was 2.33 prior to in-
cluding the SCARB1 exon variant and 2.27 after in-
cluding the SCARB1 exon 1 variant. The lower peak
LOD score is due to the loss of sample size incurred
when limiting the analysis to those subjects included in
both the linkage and association samples.
Discussion
We found evidence for genomewide linkage to ICA IMT
161 cM from the tip of the short arm of chromosome
12, with a maximum two-point LOD score of 4.1 and
multipoint LOD score of 3.4. To our knowledge, this is
the ﬁrst population-based study that has provided strong
evidence for linkage of a QTL to a measure of subclinical
atherosclerosis on a genomewide scale. We followed up
our ﬁnding of genomewide linkage with an association
study of variants in a highly plausible candidate gene,
SCARB1, in the region of linkage. Evidence for asso-
ciation of the exon 1 variant of SCARB1 with ICA IMT
was found. However, although this variant is associated
with ICA IMT, the homozygotes are quite rare, and it
does not account for the linkage observed, suggesting
that other variants in this gene or in other genes in the
region are responsible for the linkage with carotid IMT.
To date, the available evidence from genomewide
linkage analyses of atherosclerosis phenotypes derives
from selected populations. A recent report in families
with two or more affected relatives identiﬁed a region
of linkage to premature myocardial infarction on chro-
mosome 14 (LOD score 3.9) (Broeckel et al. 2002). An
additional genomewide linkage analysis performed in a
genetically isolated population in Finland that was en-
riched for subjects with premature coronary artery dis-
ease demonstrated evidence for linkage on chromosome
2 (LOD score 3.0), ∼45 million base pairs from our
peak LOD score for CCA IMT (Pajukanta et al. 2000).
Linkage to chromosome 16 (LOD score 3.1) was found
in another population with premature coronary artery
disease in Mauritius (Francke et al. 2001). A recent
study performed in 29 families enriched for hyperten-
sion showed evidence for linkage to coronary artery
calciﬁcation, assessed by electron-beam computed to-
mography (LOD score 3.2 on chromosome 10) (Lange
et al. 2002). Although these studies provide suggestive
results, each was drawn from a sample selected for pro-
bands with a high burden of cardiac risk factors or
premature atherosclerosis, or from a genetically isolated
population. Whereas the ﬁndings of these prior studies
may represent valid evidence for linkage of genetic loci
to subclinical and clinical vascular disease phenotypes
in rare families, the selected nature of the cohorts in
these studies may limit the generalizability of the results.
It is interesting that QTLs for ICA IMT and CCA
IMT map to different chromosomes and that our link-
age peak for ICA IMT is stronger than that for CCA
IMT. It has been suggested that thickening of the CCA
intima may be a better marker for total body athero-
sclerosis, whereas thickening of the ICA intima might
represent focal atherosclerotic plaques (O’Leary et al.
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Table 2
All Markers and Locations with Two-Point LOD Scores 11.0
for ICA and CCA IMT
Type and Marker Chromosome
Location
(cM) LOD Score
ICA:
D1S2134 1 76 2.37
D1S1653 1 164 1.22
D1S1678 1 218 1.86
D5S817 5 23 1.06
D5S1725 5 98 1.12
D5S1462 5 105 1.14
D7S817 7 50 1.58
D11S199 11 17 1.28
D12S2078 12 150 1.82
D12S1045 12 161 4.06
CCA:
D1S3721 1 74 1.08
D2S1790 2 103 1.57
D2S2972 2 114 1.03
D3S1768 3 62 1.16
D3S2459 3 119 1.44
D9S319 9 54 1.53
D12S1301 12 56 1.70
D12S1294 12 78 1.18
D14S606 14 92 1.75
D19S586 19 33 1.47
NOTE.—Genetic distance provided by Marshﬁeld map
location.
Figure 2 Peak multipoint LOD scores for ICA and CCA IMT by chromosome
1996). Indeed, thickening of the ICA has been shown
to be more strongly associated with incident CVD, com-
pared with the CCA (O’Leary et al. 1996). Differential
blood ﬂow in regions of arterial bifurcation, such as the
ICA, may increase thrombosis, lipid deposition, and
atherosclerosis (Grabowski and Lam 1995), whereas
laminar blood ﬂow, as seen in the CCA, is inversely
related to wall shear stress (Gnasso et al. 1996). Low
wall shear stress, via an increase in the duration of time
that blood comes into contact with the endothelial wall,
may enhance the delivery of atherogenic particles
(Gnasso et al. 1996). Thus, different pathophysiologic
mechanisms may underlie observed differences in ICA
IMT and CCA IMT, suggesting the role of unique sets
of genes in their variation.
The region on chromosome 12 near our peak LOD
score for ICA IMT contains a number of atherosclerosis
candidate genes located very close to the region of link-
age. Among them, SCARB1 is implicated in the ath-
erogenic process by a considerable body of prior re-
search. The identiﬁcation of SCARB1 (Acton et al.
1996) represented a signiﬁcant advance in understand-
ing the manner in which high-density lipoproteins
(HDL) are believed to exert their anti-atherogenic role
in cholesterol metabolism through the process of deliv-
ering cholesterol from peripheral tissues back to the
liver for removal from the body, called “reverse cho-
lesterol transport” (Stein and Stein 1999; Silver et al.
2000). SCARB1, a cell-surface glycoprotein expressed
in the liver, adrenal glands, and ovaries, was the ﬁrst
HDL receptor to be well deﬁned and characterized in
vitro and in animal studies. In murine atherosclerosis
models, the absence of SCARB1 dramatically acceler-
ates the onset of atherosclerosis (Braun et al. 2002),
whereas atherosclerosis is suppressed by hepatic over-
expression of this gene (Arai et al. 1999; Kozarsky et
al. 2000).
The human SCARB1 gene was characterized and in-
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Figure 3 Mean (SE) ICA IMT by genotype of SCARB1; data presented is unadjusted
vestigated in a southern European population by Acton
et al. (1999). Three common SNP variants were de-
scribed (with allele frequency 10.1) at exon 1 (GrA),
exon 8 (CrT), and intron 5 (CrT). The polymorphisms
at intron 5 and exon 8 are in linkage disequilibrium
with each other and are both probably nonfunctional,
whereas the SNP in exon 1 is not in linkage disequilib-
rium with either of the other two SNPs and encodes an
amino acid change from glycine to serine that modiﬁes
one of the potential acylation sites in the SCARB1 mol-
ecule. In this study by Acton et al. (1999), associations
were found between SCARB1 and both HDL and LDL
(low-density lipoproteins), suggesting that SCARB1
may play a role in the metabolism of both lipoprotein
classes in humans. In addition, associations were de-
tected with triglycerides and body mass index (Acton
et al. 1999). In a study of the Framingham Heart Study
Offspring cohort, it has been shown that statistically
signiﬁcant interactions exist between the SCARB1 exon
1 variant and type 2 diabetes. Diabetic subjects with
the less-common allele have lower lipid concentrations,
including lower LDL cholesterol and HDL cholesterol
(Osgood et al. 2003). Taken together, these data allow
us to hypothesize that the SCARB1 gene may also be
involved in several features of the metabolic syndrome.
Although our ﬁndings support a role for SCARB1 as
an atherosclerosis candidate gene, we acknowledge the
limitation that we have not demonstrated that associ-
ations of SCARB1 variants with carotid IMT explain
the linkage of chromosome 12 to carotid IMT. Our
ﬁndings illustrate the challenges inherent in attempts to
implicate a speciﬁc gene and mutation in the etiology
of complex diseases by utilizing the results of genome-
wide linkage analyses (Altshuler et al. 2000). In this
regard, we note that several other candidate genes of
interest reside near the region of linkage. For example,
the neuronal nitric oxide synthase 1 (NOS1 [MIM
163731]) gene lies near the region of peak linkage that
was found in the current study, and upregulation of
juxtaglomerular NOS1 has been shown to precede
glomerulosclerosis in fawn-hooded hypertensive rats
(Weichert et al. 2001). In human studies of asthma,
polymorphisms in the NOS1 gene were associated with
eosinophil cell counts and IgE levels (Immervoll et al.
2001). Thus, NOS1 may play a role in inﬂammation
and human atherosclerosis. Mutations in the TCF1
(MIM 142410) gene, mapped to chromosome 12q24,
have been shown to cause biliary-acid–transport de-
fects, with impaired liver-cholesterol synthesis andHDL
metabolism (Shih et al. 2001). Maturity-onset diabetes
of the young (MODY3 [MIM 600496]) is a rare, dom-
inantly inherited form of early-onset diabetes that is
caused by mutations in the hepatocyte nuclear factor-1
alpha gene (HNF-1 alpha, encoded by the TCF1 gene)
(Yamagata et al. 1996). The ATP-binding cassette, sub-
family B, member 9 (ABCB9) (Zhang et al. 2000) [MIM
605453], a member of the ABC family of genes, also
resides near the region of peak linkage that was found
in the current study. Several genes in the ABC gene
family have been shown to impact lipid metabolism
(Borst and Elferink 2002). The insulin-like growth fac-
tor 1 gene (IGF1 [MIM 147440]) also resides near the
peak linkage region and has been shown to be associ-
ated with type 2 diabetes and glucose tolerance (Frayl-
ing et al. 2002).
Some additional limitations of our study deservemen-
tion. First, because the phenotype information for the
study was not collected until 1996, we may have in-
curred a survival bias, since subjects with a greater ge-
netic predisposition inducing more severe disease may
have died prematurely or been lost to follow-up. How-
ever, this loss would likely attenuate our results. Second,
most of the subjects in our study were white, potentially
limiting the generalizability of the ﬁndings to other eth-
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nicities. Last, the sample size and the marker spacing
of 10 cM in the genomewide linkage analysis may have
limited the power of our study to localize a disease-
inﬂuencing QTL that is in linkage with carotid IMT.
However, we do not believe the low power affects the
validity of our primary ﬁndings, since we obtained a
LOD score of 3.4, which is typically regarded as of
sufﬁcient magnitude to be of nearly genomewide sig-
niﬁcance. Regardless, there are likely to be QTLs that
were not detected in our study but that contribute sig-
niﬁcantly to variability in carotid IMT, and there may
be additional genes in other regions of the genome that
we have missed, given the low power of our study.
These data suggest substantial evidence for a QTL on
chromosome 12 that inﬂuences the IMT of the ICA.
SCARB1 represents an attractive candidate gene, and a
common missense variant in exon 1 of SCARB1 or a
nearby locus is associated with lower IMT. However, we
have not demonstrated that allelic variants in this can-
didate gene explain our observed linkage. Although our
ﬁndings suggest that further investigation is warranted
to determine the role of SCARB1 in atherosclerosis, ad-
ditional variants on chromosome 12, including those in
nearby candidate genes, should be examined for evidence
of association to atherosclerosis traits. These ﬁndings
support the continued use of genomewide approaches to
discover genetic variants predisposing to quantitative
measures of subclinical atherosclerosis.
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